BESSEMER GROUP INC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 115 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2018. The put-call ratio across all filers is 2.62 and the average weighting 0.0%.

Quarter-by-quarter ownership
BESSEMER GROUP INC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2018$1,000500.0%0.00%
Q2 2018$0500.0%0.00%
Q1 2018$0500.0%0.00%
Q4 2017$0500.0%0.00%
Q3 2017$0
-100.0%
500.0%0.00%
Q2 2017$1,0000.0%500.0%0.00%
Q1 2017$1,000500.0%0.00%
Q4 2016$0
-100.0%
50
-99.1%
0.00%
Q2 2016$70,000
-18.6%
5,4000.0%0.00%
Q1 2016$86,000
-93.7%
5,400
-88.7%
0.00%
-100.0%
Q4 2015$1,367,000
+1.3%
47,705
+0.6%
0.01%0.0%
Q3 2015$1,349,000
-36.9%
47,405
-20.4%
0.01%
-27.3%
Q2 2015$2,138,000
+23.7%
59,520
+100.0%
0.01%
+22.2%
Q1 2015$1,729,000
+70.2%
29,760
+23.5%
0.01%
+80.0%
Q4 2014$1,016,00024,1000.01%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q4 2018
NameSharesValueWeighting ↓
Raging Capital Management, LLC 295,790$1,367,0000.20%
Jump Trading, LLC 42,400$196,0000.06%
GAM Holding AG 83,940$388,0000.02%
Magnus Financial Group LLC 13,393$62,0000.01%
PANAGORA ASSET MANAGEMENT INC 438,606$2,026,0000.01%
Quantamental Technologies LLC 3,898$18,0000.01%
QS Investors, LLC 155,683$719,0000.01%
SFMG, LLC 11,994$55,0000.01%
Winslow, Evans & Crocker, Inc. 4,060$20,0000.01%
MILLENNIUM MANAGEMENT LLC 812,262$3,753,0000.01%
View complete list of INSYS THERAPEUTICS INC NEW shareholders